---

Recent Peer-Reviewed Publications

• Schmidt SL, Sabet A, Wong DH, Gilden AH, Wickham EP, Raatz S, Fox CK, Gudzune KA. Development of program requirements for obesity medicine fellowship training in the U.S. Obes Pillars. 2026 Jun 8;19:100282. PMID: 42291790.
• American Diabetes Association Professional Practice Committee for Obesity. Screening, Diagnosis, Evaluation, and Staging of Obesity in Adults: Standards of Care in Overweight and Obesity-2026. BMJ Open Diabetes Res Care. 2026 Jun 4;13(Suppl 1):e006247. PMID: 42242835.
• Galindo RJ, Gudzune KA, Look M, Lee CJ, Benabbad I, Cao D, Meng Q, Mojdami D. Weight Changes With Tirzepatide and Concomitant Weight-Inducing Medications: Post Hoc Analysis of Randomized Clinical Trials. JAMA Netw Open. 2026 Mar 2;9(3):e263274. PMID: 41885866.
• Young CB, Rives E, Gudzune KA, Jaeger BC, Simmons CG, White BN, Hooker SA, Horn DB, Young DR, Vesely J, Velazquez A, Price C, Cook SD, Martin-Fernandez K, Inzhakova G, Pajewski NM, Ard JD, Lewis KH. The long-term effectiveness of the anti-obesity medication phentermine (LEAP) trial: Rationale, design, and baseline characteristics. Contemp Clin Trials. 2026 Feb;161:108219. PMID: 41519431.
• American Diabetes Association Professional Practice Committee for Obesity. Pharmacologic treatment of obesity in adults: Standards of care in overweight and obesity. BMJ Open Diabetes Res Care. 2026 Jan 13;13(Suppl 1):e005729. PMID: 41529914.
• Laudenslager M, Chae K, Tackett S, Bertram A, Gudzune KA. An obesity care curriculum improves residents’ self-efficacy and clinical practice habits. Obes Pillars. 2025 Oct 30;16:100223. PMID: 41281906.
• Khalil A, Kim AJ, Cheskin LJ, Rajagopal S, Morefield B, Chaudhry Z, Gudzune KA, Weiss CR. Establishing a multidisciplinary bariatric arterial embolization program: A two-year clinical experience. Obes Pillars. 2025 Sep 25;16:100211. PMID: 41127876.
• Brown KL, Cready G, Schmiedicker K, Vicari M, Zervios J, Kyle TK, Gudzune KA. Reimagining primary care visits for people living with obesity: A co-design and validation study. Patient Educ Couns. 2025 Sep;138:109190. PMID: 40472767.
• Ard J, Kaplan LM, Kahan S, Kumar R, Kan H, Dunn JP, Sims TJ, Ahmad NN, King-Concialdi K, Drakeley S, Jauregui A, Gudzune K. Perspectives on Obesity Management and the Use of Anti-Obesity Medicine from US Employees and Employers: Results from the OBSERVE Study. Popul Health Manag. 2025 Jun;28(3):150-160. PMID: 40170585.
• American Diabetes Association Professional Practice Committee for Obesity. Weight stigma and bias: standards of care in overweight and obesity-2025. BMJ Open Diabetes Res Care. 2025 May 16;13(Suppl 1):e004962. PMID: 40379436.
• Gudzune KA, Schwartz JL, Olsson K, Almazan E, Beck TG, Ghosh J, Bennett WL, Clark JM. Centering Weight Management Clinical Decision Support in Primary Care on Patients With Obesity and Practitioners: A Proof-Of-Concept Study. Obes Sci Pract. 2025 Feb 12;11(1):e70056. PMID: 39944719.
• Gudzune KA, Stefanski A, Cao D, Mojdami D, Wang F, Ahmad N, Ling Poon J. Association between weight reduction achieved with tirzepatide and quality of life in adults with obesity: Results from the SURMOUNT-1 study. Diabetes Obes Metab. 2025 Feb;27(2):539-550. PMID: 39497468.
• Gudzune KA, Brittan DR, Cadle AW, Reid TJ, Wickham EP 3rd, Korner J. Duties, tasks, knowledge and skills of an obesity medicine physician: A practice analysis. Obes Pillars. 2024 Oct 28;12:100147. PMID: 39553895.
• Gudzune KA, Kaplan LM, Kahan S, Kumar RB, Dunn JP, Ahmad NN, Poon JL, Sims TJ, Mackie DS, Jauregui AK, Balkaran BL, Kan H, Ard J; OBSERVE study. Weight-Reduction Preferences Among OBSERVE Study Participants With Obesity or Overweight: Opportunities for Shared Decision-Making. Endocr Pract. 2024 Oct;30(10):917-926. PMID: 38901731.
• Gudzune KA, Kushner RF. Medications for Obesity: A Review. JAMA. 2024 Aug 20;332(7):571-584. PMID: 39037780.

Please see PubMed for Dr. Gudzune’s complete bibliography

---